中国全科医学2013，Vol.16Issue(6)：598-600,3.DOI:10.3969/j.issn.1007-9572.2013.02.079
降钙素原在急性冠脉综合征和心源性休克中的预测价值研究进展
The Research Progress of Procalcitonin Prognostic Value in Acute Coronary Syndrome and Cardiogenic Shock Patients
摘要
Abstract
Inflammation plays a key role in atherosclerosis. Acute coronary syndrome ( ACS ) is an inflammatory disease. The inflammatory markers in serum, such as interleukin ( IL ) - 6, IL - 8 and C - reactive protein ( CRP ), are used to evaluate patients with coronary artery disease. Procalcitonin ( PCT ) is inflammatory factor in acute period and has been widely used as markers of infection. So far, data on serum PCT levels in patients with ACS and cardiogenic shock is scarce and controversial. This paper will review PCT prognostic value and dynamics in acute coronary syndrome and cardiogenic shock patients in details.关键词
降钙素原/冠状动脉疾病/休克,心源性Key words
Procalcitonin/ Coronary artery disease/ Shock, cardiogenic分类
医药卫生引用本文复制引用
孙志军,李虹伟..降钙素原在急性冠脉综合征和心源性休克中的预测价值研究进展[J].中国全科医学,2013,16(6):598-600,3.基金项目
国家自然科学基金项目(30971240) （30971240）
中华人民共和国教育部高等学校博士学科点专项科研基金项目(20091107110005) （20091107110005）
